Literature DB >> 24385307

A GFP endometriosis model reveals important morphological characteristics of the angiogenic process that govern benign and malignant diseases.

Daniel Escorsim Machado1, Antônio Palumbo2, João Marcos Santos3, Rômulo Medina Mattos2, Thiago Alves dos Santos3, Sergio Henrique Seabra3, Leonardo da Cunha Boldrini2, Jamila Alessandra Perini3, Luiz Eurico Nasciutti4.   

Abstract

Endometriosis involves the growth of endometriotic tissue outside the uterine cavity, and is frequently associated with different malignancies. A well-reported alteration in the disease microenvironment is the proliferation of new blood vessels around the lesions, as part of a necessary repertory to contribute to the invasiveness and development of infiltrating endometriosis. Therefore, the establishment of a reliable experimental model is essential to elucidate the contribution of angiogenesis and to develop new therapeutic approaches to endometriosis treatment. For this purpose we transplanted endometrial fragments from green fluorescent protein (GFP)-mice (n=20) into the peritoneal cavity of wild-type mice (n=20), and then analyzed the morphological changes and the process of angiogenesis. The lesions were cystic and vascularized, and showed morphological hallmarks such as endometrial glands and stroma. An increase in endometriotic lesion vascular density was revealed by immunostaining and RNAm expression for Vegf and its receptor Flk-1, and the lesions were confirmed as a tissue-donor source by GFP fluorescent cells. The same pattern was observed through staining of activated macrophages and an increase of about 25% in the number of macrophage-positive cells was also demonstrated in endometriotic lesions by flow cytometry, which concords with previous data that correlate endometriosis, angiogenesis and inflammation. According to our understanding, this is the first demonstration that the pattern of the angiogenic process in the GFP endometriosis model is very similar to that of cancer. These observations will be useful for investigation of the process of angiogenesis involved in the attachment and invasion of endometrial cells, as well as an in vivo platform model to study the effects of antiangiogenic drugs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24385307     DOI: 10.14670/HH-29.903

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

Review 1.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

2.  Inhibition of erythropoietin-producing hepatoma receptor B4 (EphB4) signalling suppresses the vascularisation and growth of endometriotic lesions.

Authors:  Jeannette Rudzitis-Auth; Sophia A Fuß; Vivien Becker; Michael D Menger; Matthias W Laschke
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

3.  Euterpe oleracea Extract (Açaí) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis.

Authors:  Daniel Escorsim Machado; Karina Cristina Rodrigues-Baptista; Jessica Alessandra-Perini; Roberto Soares de Moura; Thiago Alves Dos Santos; Kariny Gomes Pereira; Yasmin Marinho da Silva; Pergentino José Cunha Souza; Luiz Eurico Nasciutti; Jamila Alessandra Perini
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

4.  Anticancer potential, molecular mechanisms and toxicity of Euterpe oleracea extract (açaí): A systematic review.

Authors:  Jéssica Alessandra-Perini; Karina Cristina Rodrigues-Baptista; Daniel Escorsim Machado; Luiz Eurico Nasciutti; Jamila Alessandra Perini
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

Review 5.  Endometriosis in the Mouse: Challenges and Progress Toward a 'Best Fit' Murine Model.

Authors:  Katherine A Burns; Amelia M Pearson; Jessica L Slack; Elaine D Por; Alicia N Scribner; Nazmin A Eti; Richard O Burney
Journal:  Front Physiol       Date:  2022-01-13       Impact factor: 4.566

6.  Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis.

Authors:  Daniel Escorsim Machado; Jamila Alessandra Perini; Margarida Maria Camoes Orlando; Ralph Santos-Oliveira
Journal:  Biomed Res Int       Date:  2015-07-09       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.